Uganda receives 19,200 doses of twice-yearly injectable HIV prevention drug, but when and where will it be rolled out?
Uganda has received 19,200 doses of Lenacapavir, a new long-acting HIV prevention drug that is taken only twice a year ...
Uganda has received 19,200 doses of Lenacapavir, a new long-acting HIV prevention drug that is taken only twice a year ...
The High Court in Jinja has awarded Shs190 million in compensation to John Wataka after finding that The Aids Support ...
Uganda’s National Drug Authority (NDA) has approved Lenacapavir, a long-acting HIV prevention injection developed by US pharmaceutical company Gilead Sciences, ...
Minister of Health, Dr Jane Ruth Aceng, has welcomed a landmark global deal that will dramatically slash the cost of ...
The World Health Organization (WHO) has officially recommended the use of a newly approved HIV prevention drug, lenacapavir, marking a ...
Uganda is preparing to roll out Lenacapavir, a revolutionary HIV prevention injection that provides protection for six months and has ...
The US Food and Drug Administration (FDA) has approved lenacapavir for the prevention of HIV, marking a major milestone in ...
The Ministry of Health has initiated the rollout of cabotegravir (Cab-LA), a long-acting HIV prevention drug jabs, marking a new ...
The government has launched an innovative program to provide HIV-negative men with event-driven pre-exposure prophylaxis (ED-PrEP) medication to prevent HIV ...